Systemic Inflammatory Response Syndrome-Related Lymphopenia Is Associated With Adenosine A(1) Receptor Dysfunction

SIRS is associated with lymphopenia, and prolonged lymphopenia of septic patients has been associated with increased mortality risk. We hypothesize that elevated adenosine during SIRS down-regulates Gi-coupled A(1)R, which signals an effect that sensitizes a cAMP-dependent lymphotoxic response. In this study, we evaluate the role of adenosine in SIRS-mediated lymphopenia and impaired IL-15 production. Cecal ligation and puncture was used to induce sepsis-associated SIRS in mice. BMDCs were cultured and used to measure the effect of adenosine on IL-15. We found that A(1)R mRNA levels were significantly down-regulated and A(1)R-dependent Gi activity was abolished in T cells of septic mice. In accordance, cAMP was elevated in isolated T cells from cecal ligation and puncture compared with sham-treated mice. Similar to septic mice, leukopenia was evident in sham A(1)R-KO mice, after treatment with the A(1)R antagonist (8-cyclopentyl-1,3-dipropylxanthine), or after A(1)R desensitization. In contrast, A2AR-KO mice were protected from leukopenia. In addition, we observed that septic A(1)R-KO mice exhibited low IL-15 levels. Cultured BMDC agonists of A(2A)R and A(2B)R inhibited IL-15 production and adenosine blocked IL-15-dependent proliferation of cytotoxic T cells that were cocultured with stimulated BMDCs. To conclude, we suggest that SIRS-associated lymphopenia is initiated by A(1)R desensitization and adenosine-mediated inhibition of IL-15 production is part of the mechanism that accounts for the delay in leukopenia recovery in patients with severe sepsis. Interference with adenosine signaling may thus be potentially beneficial for septic patients with leukopenia.